JMI Syringes & Medical Devices Limited announcements
208 Dhaka Stock Exchange announcements for JMI Syringes & Medical Devices Limited (JMISMDL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (21).
- Alpha Credit Rating Limited (AlphaRating) has assigned the surveillance rating of the Company as \"AA-\" in the long ter
Alpha Credit Rating Limited (AlphaRating) has assigned the surveillance rating of the Company as \"AA-\" in the long term and \"ST-1\" in the short term along with a stable outlook based on audited financial statements of the Company up to June 30, 2022 and relevant qualitative information till December 05, 2022.
- Announcement of Record Date for entitlement of Stock Dividend
Referring their news disseminated by DSE on October 18, 2022 regarding Dividend Declaration, the company has further informed that the Record Date for entitlement of Stock Dividend is today i.e. November 14, 2022. The company has informed that no approval is required from Bangladesh Securities and Exchange Commission for Stock Dividend declaration. Other information will remain unchanged.
- Resumption after record date
Trading of the shares of the Company will resume on 15.11.2022 after record date.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.88 for July-September 2022 as against Tk. 0.86 for July-September 2021; NOCFPS was Tk. (3.13) for July-September 2022 as against Tk. 0.80 for July-September 2021. NAV per share was Tk. 125.13 as on September 30, 2022 and Tk. 123.55 as on September 30, 2021.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 14.11.2022
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 10.11.2022 to 13.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 14.11.2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- The auditor of the JMI Syringes & Medical Devices Ltd. has given the \"Emphasis of Matter\" paragraphs in the auditor\'s
The auditor of the JMI Syringes & Medical Devices Ltd. has given the \"Emphasis of Matter\" paragraphs in the auditor\'s report for the year ended June 30, 2022. Emphasis of Matter: We draw attention to the note no. 6.0.1 of the financial statements which describe that the store ledger is being maintained only with quantity but not with value of raw material and finished goods and thus the value of (cont.)
- Emphasis of Matter
(Continuation news of JMISMDL): raw materials and finished goods could not possible to confirm the value of raw materials and finished goods by us. Our report is not modified in this regard According to note no. 6.0.1 (Inventories) the inventories balance was BDT. 723,953,808 and BDT. 541,635,942.89 as on 30.06.2022 and 30.06.2021 respectively. (end)
The first part of this announcement is missing from the archive. - The Board of Directors has recommended 36\% stock dividend for the year ended June 30, 2022. Date of AGM: 21.12.2022, Ti
The Board of Directors has recommended 36\% stock dividend for the year ended June 30, 2022. Date of AGM: 21.12.2022, Time: 11:30 AM, Venue: Digital Platform. Record Date: 14.11.2022. The Company has also reported EPS of Tk. 4.55, NAV per share of Tk. 124.25 and NOCFPS of Tk. 1.85 for the year ended June 30, 2022 as against Tk. 4.03, Tk. 122.70 and Tk. 8.38 respectively for the same period of the previous year. (cont.1)
- (Continuation news of JMISMDL): Reasons for declaration of stock dividend: i) Bonus shares have been recommended for inc
(Continuation news of JMISMDL): Reasons for declaration of stock dividend: i) Bonus shares have been recommended for increasing minimum paid-up capital BDT 30 Crore. ii) Bonus shares have declared out of the accumulated profit or retained earnings. (cont.2)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (18.10.2022) following its corporate declaration.
- Dividend Declaration
(Continuation news of JMISMDL): iii) Bonus shares are not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the Company or through reducing paid up capital or through doing anything so that the post dividend retained earnings become negative or a debit balance. (end)
The first part of this announcement is missing from the archive. - Dividend Declaration (Correction News)
(Correction News): The Board of Directors has recommended 36% stock dividend subject to approval of BSEC for the year ended June 30, 2022. Date of AGM: 21.12.2022, Time: 11:30 AM, Venue: Digital Platform. Record Date: 14.11.2022 only for the shareholders' decision in the general meeting (not for entitlement of Stock Dividend). Record date for entitlement of Stock Dividend will be notified later after getting approval from BSEC. Other information will remain unchanged. (end)
- Update of Information
The Company has requested the Shareholders to update their respective BO Accounts with 12 digits Tax Payers' Identification Numbers (e-TIN), Bank Accounts, Routing Numbers, Mailing addresses, Contact Numbers, e-mail ID(s) through their respective depository participants (DP) before Record Date.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 17, 2022 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 1.40 for January-March 2022 as against Tk. 0.77 for January-March 2021; EPS was Tk. 4.30 for July 2021-March 2022 as against Tk. 3.65 for July 2020-March 2021. NOCFPS was Tk. (2.32) for July 2021-March 2022 as against Tk. 3.70 for July 2020-March 2021. NAV per share was Tk. 123.99 as on March 31, 2022 and Tk. 122.70 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 26, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 2.04 for October-December 2021 as against Tk. 2.08 for October-December 2020; EPS was Tk. 2.90 for July-December 2021 as against Tk. 2.88 for July-December 2020. NOCFPS was Tk. (1.67) for July-December 2021 as against Tk. 2.20 for July-December 2020. NAV per share was Tk. 122.60 as on December 31, 2021 and Tk. 122.70 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 26, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.